(Rac)-Byakangelicin
CAS No. 19573-01-4
(Rac)-Byakangelicin ( —— )
Catalog No. M21818 CAS No. 19573-01-4
(Rac)-Byakangelicin is a racemate of Byakangelicin mainly isolated from the genus Angelica. Byakangelicin is an aldose-reductase inhibitor with an IC50 value of 6.2 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(Rac)-Byakangelicin
-
NoteResearch use only, not for human use.
-
Brief Description(Rac)-Byakangelicin is a racemate of Byakangelicin mainly isolated from the genus Angelica. Byakangelicin is an aldose-reductase inhibitor with an IC50 value of 6.2 μM.
-
Description(Rac)-Byakangelicin is a racemate of Byakangelicin mainly isolated from the genus Angelica. Byakangelicin is an aldose-reductase inhibitor with an IC50 value of 6.2 μM.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number19573-01-4
-
Formula Weight334.32
-
Molecular FormulaC17H18O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C=CC2=C(OC)C3=C(OC=C3)C(OCC(O)C(C)(O)C)=C2O1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. A. Douglas Kinghorn, et al. Progress in the Chemistry of Organic Natural Products. 2019, volume 108.
molnova catalog
related products
-
(-)-Isopulegol
Isopulegol has antioxidant, and neuroactive properties. It also has gastroprotective effects induced by isopulegol appear to be mediated, at least in part, by endogenous prostaglandins, K+ATP channel opening and antioxidant proprieties related to GSH increased.
-
Solvent Yellow 16
Solvent Yellow 16, a disperse dye, is a coloring agent in cosmetics.
-
Dolasetron Mesylate
Dolasetron Mesylate is an antagonist of the 5-HT3 receptor and can be used in research on the treatment of vomiting and nausea following chemotherapy.